AVITA Medical (RCEL) Other Non-Current Assets (2019 - 2025)
AVITA Medical (RCEL) posted Other Non-Current Assets of $612000.0 for Q4 2025, down 43.02% on a QoQ basis from $1.1 million in Q3 2025, and up 12.09% year-over-year from $546000.0 in Q4 2024.
AVITA Medical (RCEL) Other Non-Current Assets (2019 - 2025) Analysis & Trends
AVITA Medical's Other Non-Current Assets history runs 7 years deep, the most recent figure standing at $612000.0 for Q4 2025.
- Quarterly Other Non-Current Assets rose 12.09% year-over-year to $612000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $612000.0 (up 12.09% YoY) and the FY2025 annual result came in at $612000.0, up 12.09% from the prior year.
- Other Non-Current Assets was $612000.0 for Q4 2025 at AVITA Medical, down from $1.1 million in the prior quarter.
- Across five years, Other Non-Current Assets topped out at $1.1 million in Q3 2025 and bottomed at $122000.0 in Q4 2022.
- A 5-year average of $437550.0 and a median of $378000.0 in 2023 frame the typical range for Other Non-Current Assets.
- Annual changes were most pronounced in 2021 — Other Non-Current Assets soared 278.61% — and 2022, when it plunged 73.46%.
- AVITA Medical's Other Non-Current Assets stood at $201000.0 in 2021, then sank by 39.3% to $122000.0 in 2022, then surged by 190.98% to $355000.0 in 2023, then jumped by 53.8% to $546000.0 in 2024, then increased by 12.09% to $612000.0 in 2025.
- Business Quant data shows RCEL's Other Non-Current Assets at $612000.0 in Q4 2025, $1.1 million in Q3 2025, and $839000.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | - |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 3.17 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 4.15 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 2.05 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 738.90 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 285.90 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 828.89 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 2.25 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | 164.00 Mn |
| 10 | AVITA Medical | 140.94 Mn | 124.59 Mn | 14.31 Mn | 612,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 612,000.00 |
| Sep 30, 2025 | 1.07 Mn |
| Jun 30, 2025 | 839,000.00 |
| Mar 31, 2025 | 287,000.00 |
| Dec 31, 2024 | 546,000.00 |
| Sep 30, 2024 | 546,000.00 |
| Jun 30, 2024 | 473,000.00 |
| Mar 31, 2024 | 401,000.00 |
| Dec 31, 2023 | 355,000.00 |
| Sep 30, 2023 | 236,000.00 |
| Jun 30, 2023 | 285,000.00 |
| Mar 31, 2023 | 230,000.00 |
| Dec 31, 2022 | 122,000.00 |
| Sep 30, 2022 | 548,000.00 |
| Jun 30, 2022 | 202,000.00 |
| Mar 31, 2022 | 201,000.00 |
| Dec 31, 2021 | 201,000.00 |
| Sep 30, 2021 | 201,000.00 |
| Jun 30, 2021 | 761,000.00 |
| Mar 31, 2021 | 631,000.00 |